Trading Woche
Fresenius, DE000FRE5EN2

Fresenius stock pre-market at EUR 41.81: minus 0.05 percent

Published on 10/09/2026 at 07:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At Lang & Schwarz, Fresenius was at EUR 41.81 pre-market on October 9, 2026, down 0.05 percent from the EUR 41.83 prior close.

Key points in brief

  • Fresenius traded at EUR 41.81 pre-market.
  • The stock was down 0.05 percent versus the prior close.
  • Fresenius lists its Q3 2026 conference call for November 4, 2026.
Fresenius SE – Fotorealistisch: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht
Fresenius SE & Co. KGaA (ISIN DE0005785604) ist ein internationaler Gesundheitskonzern mit Sitz in Bad Homburg. Das Unternehmen betreibt Krankenhäuser und entwickelt Arzneimittel und Infusionslösungen. Dieses Bild zeigt: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht, Illustration mit AI erstellt.

Fresenius stock was at EUR 41.81 pre-market at Lang & Schwarz on October 9, 2026, at 7:42 a.m. CEST. The price was down 0.05 percent versus the EUR 41.83 prior close at Lang & Schwarz on October 8, 2026.

Pre-market trading

The bid was EUR 41.68 and the ask was EUR 41.93. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Fresenius stock.

What matters today

Fresenius lists its Q3 2026 telephone conference for November 4, 2026, according to its Investor Relations page. A round-number level of EUR 42.00 is 0.45 percent above the pre-market price. The quoted bid and ask were EUR 41.68 and EUR 41.93, respectively.

Market context: Market report DAX.

More news and analysis on Fresenius stock

Disclaimer...

en | DE000FRE5EN2 | FRESENIUS | boerse | 70272272 | bgmi